Skip to main content
SpringerLink
Log in

Agammaglobulinaemia-tyrosine-kinase-inhibitors/cyclophosphamide/fludarabine

Hepatitis-B virus reactivation: case report

  • Case report
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Yan Z, et al. Low incidence of hepatitis B virus reactivation in patients with hematological malignancies receiving novel anticancer drugs: A report from a high epidemic area and literature review. [Review]. Journal of Microbiology, Immunology and Infection 56 : 747-756, No. 4, Aug 2023. Available from: URL: http://doi.org/10.1016/j.jmii.2023.04.003

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Agammaglobulinaemia-tyrosine-kinase-inhibitors/cyclophosphamide/fludarabine. Reactions Weekly 1977, 19 (2023). https://doi.org/10.1007/s40278-023-47093-5

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-023-47093-5

Search

Navigation